ACTIVIDADES SVEDyN

Sin eventos

CALENDARIO DE EVENTOS

Junio 2019
L M X J V S D
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial

E-mail Imprimir PDF

Lancet Diabetes & Endocrinology 2018 February

Abstract